Monport Happy Halloween
Press Release

Key Enabling Technologies, Like AI, Will Fuel the Build-Up Toward the Metaverse, Keeping the Path Open to 1 Billion Users by 2030

NEW YORK, Oct. 19, 2023 /PRNewswire/ — The metaverse may have fallen off its peak hype cycle, but progress continues to advance outside the spotlight. The future metaverse, however, was already in progress as a confluence of trends and changes within digital markets, key enabling technologies, and devices/interfaces. While these pillars are developing asymmetrically from […]

Read More
Canadian Solar Successfully Issues a JPY 18.5 Billion Green Samurai Private Placement in Japan
Press Release

Creality ShareFest Maryland 2023: Celebrating innovation and inspiration with 3d printing

EDGEWOOD, Md., Oct. 19, 2023 /PRNewswire/ — Creality, a distinguished leader in the 3D printing industry, is elated to announce the resounding success of ShareFest Maryland 2023, our second ShareFest user event. Hosted on October 1st in the charming locale of Edgewood, Maryland in USA, ShareFest continued its commitment to unite and empower the global […]

Read More
Monport Happy Halloween
Press Release

Bamboo Rose Accelerates Next Generation of Retailer and Supplier Collaboration with Supply Pilot Acquisition

Combination of Bamboo Rose and Supply Pilot will empower active supplier engagement throughout the entire retail lifecycle, from ideation to delivery.  BOSTON, Oct. 19, 2023 /PRNewswire/ — Bamboo Rose, the leading collaborative product development, sourcing, and supply chain platform for global retailers announced today its acquisition of Supply Pilot of Nottingham, UK. Bamboo Rose acquires Supply […]

Read More
SKF confirms closure of Luton factory
Press Release

Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)

Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hummingbird Bioscience to receive upfront and milestone payments up to $430 million, plus royalties, from Endeavor BioMedicines Investigational New Drug (IND) application planned in first half of 2024 SAN DIEGO, HOUSTON and SINGAPORE, Oct. 19, 2023 /PRNewswire/ […]

Read More
Monport Happy Halloween
Press Release

Malteurop sets out to conquer new markets, with the inauguration of its new malthouse in Mexico

REIMS, France and MEOQUI, Mexico, Oct. 19, 2023 /PRNewswire/ — Vivescia Group, a French cooperative agri-food group with operations in 25 countries around the world, today inaugurated a new malthouse for its malting business in Meoqui (Chihuahua state – North Mexico), in the presence of all the stakeholders involved in the project.  From left to […]

Read More
SKF confirms closure of Luton factory
Press Release

WiMi Proposed Multi-View Fusion Algorithm Based on Artificial Intelligence Machine Learning

BEIJING, Oct. 19, 2023 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that its R&D team applied machine learning algorithms to image fusion and introduced a multi-view fusion algorithm based on artificial intelligence machine learning. Multi-view fusion algorithm based on artificial […]

Read More
Robin Li, Co-founder, Chairman and CEO of Baidu, announced ERNIE 4.0 at Baidu World 2023
Press Release

NUS scientists develop innovative magnetic gel that heals diabetic wounds three times faster

First-of-its-kind cell therapy promotes wound healing, improves overall wound health and lowers risks of recurrence SINGAPORE, Oct. 19, 2023 /PRNewswire/ — Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal. Such non-healing wounds could cause serious infections resulting in painful outcomes such as limb amputation. To address […]

Read More
Fosun Showcases LANVIN, Oriental Haute Couture and Yuyuan Original at WDCC 2023
Press Release

Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023

JINAN, China, Oct. 19, 2023 /PRNewswire/ — Data from Qilu Pharmaceutical’s clinical trial of its novel bifunctional antibody, QL1706 (iparomlimab and tuvonralimab), will be unveiled during a mini oral presentation at the European Society for Medical Oncology (ESMO) Annual Congress 2023. The ESMO Congress, the premier global conference in the field of medical oncology, will take place in […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.